Oxurion
Alfred Aronson possesses extensive experience in human resources management, currently serving as Director of Human Resources at ThromboGenics since December 2011. Prior to this role, Alfred held the position of Associate Director of Human Resources at ImClone Systems, a subsidiary of Eli Lilly and Company, from 2009 to 2011. Alfred's career in the field of human resources began at Novartis, where a commitment to strategic HR leadership was demonstrated over a 12-year tenure from 1987 to 1999 as Director of HR.
This person is not in any teams
This person is not in any offices
Oxurion
Oxurion (Euronext Brussels: OXUR - formerly known as ThromboGenics) is a biopharmaceutical company developing treatments to preserve vision in patients with diseases affecting the back of the eye. The company has built a diverse portfolio of disease-modifying therapies, including treatments for diabetic eye disease, a leading cause of blindness in people of working age worldwide.